FDA changes therapeutic equivalence rating for Accord Healthcare's tacrolimus News item 23 September 2023 Pages: 5 - 5
FDA issues warning letters about unapproved eye disorder therapies News item 23 September 2023 Pages: 6 - 6
Infusion-related reactions, allergic or pseudo-allergic, potentially serious Media release 23 September 2023 Pages: 7 - 7
Vanishing bile duct syndrome due to drug-induced liver injury News item 23 September 2023 Pages: 8 - 8
ADHD therapy medication errors in paediatric patients Clinical study 23 September 2023 Pages: 10 - 10
Pegcetacoplan-related injection site reactions do not reduce compliance Clinical study 23 September 2023 Pages: 12 - 12